Guerroui S, Aubourg P, Chen W W, Hashimoto T, Scotto J
INSERM U 56, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France.
Biochem Biophys Res Commun. 1989 May 30;161(1):242-51. doi: 10.1016/0006-291x(89)91587-8.
Immunoblot analysis of peroxisomal beta-oxidation enzymes proteins was carried on liver samples from 15 patients with peroxisomal disorders in which accumulation of very long chain fatty acids was always observed in plasma. In 11 cases including 4 cerebro-hepatorenal syndrome (CHRS), 4 neonatal adrenoleukodystrophy (NALD) and 3 infantile Refsum's disease, the liver peroxisomes could not be detected by electron microscopy. Immunoblot analysis revealed the absence, or presence in weak amounts, of the 72-kDa subunit of acyl-CoA oxidase, and the complete absence of the 52-kDa and 21-kDa subunits which are processed from the 72-kDa. The bifunctional protein (78-kDa) was absent or very reduced, as was the mature form of peroxisomal 3-ketoacyl-CoA thiolase (41-kDa). Multiple defects of peroxisomal beta-oxidation enzymes may be caused by an absence of synthesis or an inability to import proteins into peroxisomes in these patients. One patient, diagnosed as NALD, had no detectable liver peroxisomes but the presence, in normal amounts, of the three peroxisomal beta-oxidation enzyme proteins suggests that the transport of these enzymes into "peroxisomal ghosts" was still intact. The last 3 patients, clinically diagnosed as NALD, had normal liver peroxisomes. One patient had an isolated deficiency of the bifunctional protein and the 2 others had normal amounts of the 3 peroxisomal beta-oxidation enzymes, as shown by immunoblotting. This suggests that import and translocation of some peroxisomal proteins had occurred and that a mechanism is therefore required to explain the defect in these patients.
对15例过氧化物酶体疾病患者的肝脏样本进行了过氧化物酶体β-氧化酶蛋白的免疫印迹分析,这些患者血浆中总是观察到极长链脂肪酸的蓄积。在11例患者中,包括4例脑肝肾综合征(CHRS)、4例新生儿肾上腺脑白质营养不良(NALD)和3例婴儿型Refsum病,通过电子显微镜无法检测到肝脏过氧化物酶体。免疫印迹分析显示,酰基辅酶A氧化酶的72-kDa亚基缺失或含量微弱,且完全不存在由72-kDa加工而来的52-kDa和21-kDa亚基。双功能蛋白(78-kDa)缺失或显著减少,过氧化物酶体3-酮酰基辅酶A硫解酶的成熟形式(41-kDa)也是如此。这些患者过氧化物酶体β-氧化酶的多重缺陷可能是由于蛋白质合成缺失或无法将蛋白质导入过氧化物酶体所致。1例被诊断为NALD的患者肝脏过氧化物酶体无法检测到,但三种过氧化物酶体β-氧化酶蛋白含量正常,这表明这些酶向“过氧化物酶体空壳”的转运仍然完好。最后3例临床诊断为NALD的患者肝脏过氧化物酶体正常。免疫印迹显示,1例患者双功能蛋白单独缺乏,另外2例患者三种过氧化物酶体β-氧化酶含量正常。这表明一些过氧化物酶体蛋白已发生导入和易位,因此需要一种机制来解释这些患者的缺陷。